BSGCT is directed and run by a board of volunteers. Board members are elected by nomination and vote at the Annual General Meeting, usually held during the Annual Conference. If you would like to express an interest in becoming a board member please don’t hesitate to contact us and we will let you know when the next call for nominations is made.

Meet the BSGCT Board

Professor Uta Griesenbach – President
Imperial College London
Professor Sian Harding
Imperial College London
Professor Stuart Nicklin – General Secretary
University of Glasgow
Dr Ralph Hector
University of Edinburgh
Professor Rafael J. Yáñez-Muñoz – Treasurer
Royal Holloway, University of London
Dr Lisa McArthur – Early Career Representative
University of Glasgow
Dr Ivana Barbaric
Centre for Stem Cell Biology, The University of Sheffield
Dr Gerry McLachlan
University of Edinburgh
Robyn Bell – Early Career Representative
Imperial College London
Dr Mustafa Munye
Cell and Gene Therapy Catapult
Dr Carly Bliss – Early Career Representative
Cardiff University
Professor Alan Parker
Cardiff University
Dr Christos Georgiadis
UCL Great Ormond Street Institute of Child Health
Dr Linda Popplewell
Royal Holloway University of London
Association Management – WATS.ON Ltd
Gaëlle Jamar


Welcome to the British Society of Gene and Cell Therapy (BSGCT)
Gene and cell therapies have entered a very exciting area with several new treatments now licensed. There is clearly lots to talk about. Traditionally the BSGCT alternates a 3-day conference and a 1-day conference. I hope you all agree that the 2017 3-day conference, which was held in Cardiff, was a great success.

To accommodate the ever growing community and scientific content we decided to deviate from the historical format slightly and will run two 1-day conferences in 2018; one in April and one in November. Over the last years we have also outgrown the Institute of Child Health conference facilities and both 2018 conferences will be held in the Regent’s Park Conference Centre in London, which is a lovely venue that fulfils our requirements.

Running two 1-day conferences in 2018 is undoubtedly an experiment, but we count on your support and very much value your feedback. The conferences have specific themes, which will be of interest to a large number of scientists and clinicians.

April conference: Lentiviral and other retroviral vectors in 2018: Applications, production and vector design relevant for translation into human
November conference: Gene editing for gene and cell therapy: Technologies, models and translation

I look forward to seeing you at both conferences.

With best wishes

Uta Griesenbach (BSGCT President)

Join the Board

Nominations are invited from BSGCT members for election to the Board of the BSGCT. Board members serve for a 3 year term, and are eligible for re-election for a further 3 years. Currently there are 3 vacancies to be filled.

Candidates for election to membership of the Board must be members of the Society, and nominations should be supported by two current BSGCT members.

The closing date for nominations is Monday 26th October 2020.